MELBOURNE, Australia, Sept. 22, 2026 /PRNewswire/ — Smashbox Cosmetics, in partnership with RUSSH Magazine, has announced the arrival of the ‘Dual Filter Studio’, an immersive two-day experiential pop-up in the heart of Melbourne’s CBD. The activation celebrates the launch of the brand’s new Dual Filter 2-in-1 Concealer + Foundation (RRP $67 AUD), now available to shop at MECCA.

Located at 362 Little Collins Street, the event invites guests to step inside the immersive pop-up for complimentary product sampling, makeup touch-ups, a professional studio photo session, and a custom lamington.

“We are thrilled to bring the Dual Filter Studio concept to Melbourne in partnership with RUSSH Magazine,” says Felix Backhaus, Senior Manager, International Commercial & Marketing at Smashbox. “Positioning this activation just steps from the MECCA flagship store on Bourke Street creates the perfect synergy for our launch and gives our community a seamless way to experience our brand and our newest launch.”

Event Details

• Dates: Tuesday, 22 September & Wednesday, 23 September
• Hours: 11:00 AM – 7:00 PM daily
• Location: 362 Little Collins Street, Melbourne VIC 3000
• Admission: Open to the public; no tickets required

Every attendee will receive a full-sized Smashbox product and complimentary treats upon entry, while supplies last.

The Smashbox Dual Filter 2-in-1 Concealer + Foundation is available to purchase in-store and online at MECCA.

ABOUT SMASHBOX COSMETICS: 
“Everything carries out of the studio into reality.” – Davis Factor

Born in a Los Angeles photo studio in 1990 by acclaimed celebrity and fashion photographer Davis Factor, Smashbox very quickly became a creative hub for world-class photographers, actors, models and musicians. The creative energy on set showed no signs of slowing down – except when the team had to stop for makeup touch ups. In 1996, Smashbox Cosmetics was officially born.

In 2000, Davis created Photo Finish Smooth & Blur, our original long-lasting primer. Now a cult-favorite, the formula helps makeup look flawless, feel better, and last longer—all day, every day, on set, and long after the shoot wraps. 

Today, Smashbox carries that legacy with studio-grade, high-performance makeup that makes artistry easy—and always camera-ready.

Instagram: @smashboxcosmetics | TikTok: @smashboxcosmetics

For press inquiries, interviews and more information please contact Franny Cowap at Hatrik House at franny@hatrikhouse.com.

Global study brings together nine Taiwan medical centers, seven Swedish sites, and four U.S. centers to evaluate an oral therapy focused on autolysosomal biology

TAIPEI, Sept. 22, 2026 /PRNewswire/ — Merry Life Biomedical today announced the advancement of TML-6, a Taiwan-developed investigational oral therapy for early Alzheimer’s disease, into a global Phase 2 study spanning Taiwan, Sweden, and the United States.

The study brings together 20 clinical sites, including nine medical centers in Taiwan, seven sites in Sweden, and four centers in the United States. It will evaluate TML-6 in approximately 210 participants with early Alzheimer’s disease.

A New Approach to Alzheimer’s Disease

Alzheimer’s disease is characterized by the abnormal accumulation of proteins in and around brain cells, including amyloid plaques and tau tangles. Recently approved therapies have demonstrated that removing amyloid can slow clinical decline in people with early Alzheimer’s disease. But even with treatment, the disease continues to progress.

TML-6 is being investigated through a new and potentially complementary approach. Research on TML-6 has increasingly focused on the autophagy–lysosomal pathway, which is responsible for clearing and recycling proteins and other cellular material. Preclinical studies have investigated its effects on autophagy lysosomal function in neurons and microglia, together with amyloid related pathology, oxidative stress, and inflammation.

“The next generation of Alzheimer’s therapeutics must look beyond what accumulates in the brain and ask why neurons lose their ability to clear damaged proteins and maintain normal function,” said Dr. Ih-Jen Su, Founder and Chairman of Merry Life Biomedical. “Research on TML-6 has increasingly pointed us toward the autophagy–lysosomal system, a fundamental cellular pathway for clearing and recycling damaged proteins and cellular components. This global Phase 2 study will test whether targeting this biology can translate into meaningful benefit for patients.”

Swedish Alzheimer’s Clinical Trial Expertise Comes to Taiwan

A major international component of the TML-6 program is the participation of seven clinical sites in Sweden, working with Anne Börjesson-Hanson, MD, PhD, of Karolinska Institute and Karolinska University Hospital.

Dr. Börjesson-Hanson is an experienced investigator in international Alzheimer’s clinical trials, including studies of emerging disease-modifying therapies. Her clinical trial experience includes serving as Sweden’s Clinical Trial Network establishment and participated in more than 40 global clinical trial as primary investigator, as well as leadership roles in other international Alzheimer’s studies.

On October 4, Dr. Börjesson-Hanson will visit Taiwan for the Taiwan Dementia Society Annual Scientific Meeting. She will deliver a plenary lecture and meet with the nine Taiwanese principal investigators participating in the TML-6 study.

Nine Taiwan Medical Centers Join the TML-6 Global Study

Nine major Taiwan medical centers are participating in the same global Phase 2 study alongside the Swedish and U.S. sites, making Taiwan the largest group of participating clinical sites in the program.

“For Taiwan’s biotechnology sector, this represents more than the advancement of one molecule,” Dr. Su said. “It is an opportunity for a therapeutic program developed in Taiwan to contribute to the global effort to understand and treat Alzheimer’s disease through a new biological approach.”

The randomized, double-blind, placebo-controlled study will enroll approximately 210 participants with early Alzheimer’s disease. Participants will receive TML-6 100 mg, TML-6 200 mg, or placebo once daily for 52 weeks. The primary endpoint is change from baseline in the Clinical Dementia Rating Sum of Boxes, a measure of cognition and daily function, and blood biomarkers p-Tau 217, Aβ, GFAP, and NfL as secondary endpoints.

The study also brings together international expertise in Alzheimer’s biomarkers, imaging, and clinical development. Henrik Zetterberg, MD, PhD, will support blood biomarker analyses, while Barbara B. Bendlin, PhD, will contribute expertise in amyloid PET and MRI analyses. Gary W. Small, MD, serves as a global medical consultant, and Jacobo Mintzer, MD, advises on global clinical site execution.

Global Phase 2 Marks a Key Value Inflection Point for Business Development and Licensing

With TML-6 advancing into global Phase 2 development, Merry Life Biomedical is moving beyond early-stage safety evaluation toward the generation of clinical efficacy, biomarker, and imaging data. The company views the global Phase 2 study as a key value inflection point and, based on study progress and emerging data, will plan for Phase 3 development and broader global development strategies. Merry Life Biomedical is also actively exploring strategic investment, international venture capital, capital-market financing, and partnerships with global pharmaceutical companies to accelerate subsequent development. In parallel, the company will continue discussions with international pharmaceutical companies and strategic partners and, subject to Phase 2 results and regulatory strategy, evaluate licensing, co-development, and other partnership models to advance TML-6 through late-stage clinical development and toward global commercialization.

Forward-Looking Statements

This press release contains forward-looking statements regarding TML-6 and its clinical development that are subject to risks and uncertainties inherent in drug development. Statements regarding TML-6’s mechanism and potential effects reflect hypotheses under clinical investigation and do not establish safety or efficacy.

MEXICO CITY, Sept. 22, 2026 /PRNewswire/ — ESENTIA Energy Development, S.A.B. de C.V. (BMV: ESENTIA) (“ESENTIA” or the “Company”) today announced that it has entered into an agreement to acquire 100% of the equity interests of Energía Occidente de México, S. de R.L. de C.V. (“EOM”) for a gross purchase price of US$400 million (the “Acquisition” or the “Transaction”).

EOM owns and operates the approximately 313-km Guadalajara-Manzanillo natural gas pipeline system (the “Guadalajara-Manzanillo System”). The system runs from the Guadalajara area in Jalisco to Manzanillo, Colima, and is directly interconnected with ESENTIA’s existing pipeline Villa de Reyes-Aguascalientes-Guadalajara system operated by Esentia Pipeline de Occidente, S. de R.L. de C.V. (“VAG”), an indirect subsidiary of the Company.

Upon completion of the Transaction, the Guadalajara-Manzanillo System would extend ESENTIA’s integrated pipeline network to the Port of Manzanillo on Mexico’s Pacific coast. As a result, ESENTIA would become the only private company with an integrated natural gas pipeline system connecting the Permian Basin in Texas to the Mexican Pacific coast.

Esentia believes that the combination of the Guadalajara–Manzanillo System with its existing infrastructure will result in highly valuable operational synergies and cost savings over time and provide additional commercial flexibility across the combined corridor.

“The Acquisition is consistent with ESENTIA’s strategy to build a cohesive cross-border transportation system through disciplined M&A and low-risk opportunities that capitalize on our existing infrastructure” said Daniel Bustos, Chief Executive Officer. “The Acquisition would expand ESENTIA’s ability to serve existing and prospective customers within the combined system’s area of influence, including demand from power generation, industrial customers and potential LNG-related projects, and help reinforce ESENTIA’s position as one of Mexico’s leading natural gas transportation platforms.”

The Acquisition will be consummated pursuant to an equity purchase agreement entered into today with respect to 100% of the equity interests of EOM, among certain subsidiaries of ESENTIA as purchasers, and TC Energía Mexicana, S. de R.L. de C.V. and TCPL CentrOriente Ltd., as sellers.

The Company expects to fund the purchase price of the Acquisition through a combination of available liquidity and/or available borrowings under existing credit facilities, and the Transaction is not expected to increase the Company’s gross indebtedness. The consummation of the Acquisition is subject to customary closing conditions, regulatory approvals and consents.

Citigroup is acting as financial advisor to ESENTIA in connection with the Transaction.

The Acquisition constitutes a corporate restructuring pursuant to the “General Provisions Applicable to Securities Issuers and Other Securities Market Participants” (Disposiciones de carácter general aplicables a las emisoras de valores y a otros participantes del mercado de valores), published in the Official Gazette of the Federation (Diario Oficial de la Federación) on March 19, 2003 (as amended from time to time, the “Issuers’ Circular”). The Transaction was approved by ESENTIA’s Board of Directors on September 4, 2026. At such time, the potential Acquisition and the related negotiation process were confidential, as agreed with the sellers and EOM.

Pursuant to Article 35, Section I, of the Issuers’ Circular, the Company does not have the accounting information necessary to prepare the required information memorandum as of the date hereof. Accordingly, the Company will defer the publication of the information memorandum to no later than the business day immediately following the date on which the necessary information becomes available, which the Company expects will occur within no more than 80 (eighty) calendar days from the date hereof.

About the Guadalajara–Manzanillo System:

The Guadalajara–Manzanillo System is an approximately 313-kilometer natural gas transportation system extending between the Guadalajara area in Jalisco and Manzanillo, Colima.

The system is connected to the LNG Manzanillo regasification terminal, located on Mexico’s Pacific coast, and consists of two principal segments:

• Segment 1 consists of an approximately 5.5-kilometer, 24-inch pipeline with transportation capacity of approximately 500 MMcf/d. The segment connects the LNG Manzanillo regasification terminal with Comisión Federal de Electricidad’s CT Manzanillo power generation facility.
• Segment 2 consists of an approximately 307.3-kilometer, 30-inch pipeline with transportation capacity of approximately 360 MMcf/d. The segment extends from the Manzanillo area toward Guadalajara and interconnects with the Sistema de Transporte y Almacenamiento Nacional Integrado de Gas Natural (“SISTRANGAS”) and Esentia’s VAG system near Guadalajara, Jalisco. 

About ESENTIA Energy Systems:

ESENTIA Energy Systems is a leading company in Mexico’s energy sector, specializing in the transportation and commercialization of natural gas. With more than 20 years of experience, we develop infrastructure projects that drive growth and expand access to energy, contributing to Mexico’s well-being and sustainable development. We operate Mexico’s largest interconnected natural gas system, supplying reliable, low-cost natural gas from Waha, Texas, through the center of the country to major industrial regions. At ESENTIA Energy Systems, we operate under the highest safety standards and maintain a firm commitment to sustainability and respect for the communities where we operate. For more information, visit www.esentiaenergy.com

Forward-looking statements

This press release contains statements that constitute estimates and forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the Acquisition including (i) projections, predictions, expectations, estimates, or forecasts as to our business, our results of operations and financial condition, our future economic performance and the general economic conditions, (ii) plans, objectives or goals, including those related to financial, operational or service performance, and (iii) statements of assumptions underlying the aforementioned statements and any other similar statements concerning matters that are not historical facts. Words such as “believe,” “expect,” “may,” “potential,” “will,” “would” and similar words are intended to identify estimates and forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements are based on our current expectations and assumptions of future events and trends which affect, or may affect, our business prospects, financial condition and results of operations. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that the predictions, forecasts, projections and other forward-looking statements will not be achieved. Future events or circumstances could cause our actual business prospects, financial condition and results of operations to differ materially from those contemplated by the forward-looking statements. Our forward-looking statements, expectations and assumptions, as well as our actual business prospects, results of operations and financial condition, may be influenced by, among others, the following factors: risks and uncertainties relating to the transactions contemplated by the Acquisition, including the occurrence of any event, change or other circumstance that could give rise to the right of us or the sellers to terminate the equity purchase agreement the possibility that the Acquisition does not close when expected or at all because of required regulatory, stockholders’, or other approvals and other conditions to closing are not received or satisfied on a timely basis or at all (and the risk that seeking or obtaining such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the Acquisition); that efforts to complete the Acquisition may affect our business relationships with our existing and potential customers, suppliers, service providers and other business partners; the risk that the expected synergies from the Acquisition may not be fully realized or may take longer to realize than expected; any failure to promptly and effectively integrate our business and that of EOM; and that the diversion Acquisition may divert of management’s attention and time to the Acquisition from ongoing business operations and opportunities. All forward-looking statements contained in this press release are qualified in their entirety by these risks, uncertainties and other unknown factors that could affect our business and we cannot assess the impact of all such factors on our business.

SYDNEY, Sept. 22, 2026 /PRNewswire/ — TMGM and Chelsea Football Club today announced the extension of their partnership into a fourth year, with the collaboration expanding beyond Asia-Pacific into the Middle East.

Since 2023, TMGM has served as Chelsea FC’s Official Online Forex and CFD Trading Partner in Asia-Pacific. The extension advances a partnership spanning matchday visibility, original content and fan engagement.

Three Years of Shared Momentum

In 2026, the partnership reached a milestone when TMGM branding appeared on the back of Chelsea men’s match shirts during the FA Cup – a first in the club’s history. TMGM also joined Chelsea FC’s 2026 Asia-Pacific Pre-Season Tour as an Official Partner, with open training, pitch-side access and post-match tunnel experiences. The tour included a visit by Chelsea players Cole Palmer and João Pedro to TMGM’s Sydney headquarters.

Earlier in 2026, TMGM presented The Famous CFC in Bangkok, where hundreds of supporters attended a live match screening and an exclusive appearance by former Chelsea captain John Terry.

These milestones formed part of a wider programme of premium home-match hospitality, behind-the-scenes visits at Cobham and player-led content under TMGM’s “Trade like a lion” campaign.

A Broader Platform for Year Four

In year four, TMGM’s expanded regional rights will support brand visibility at Chelsea home fixtures, original content featuring players and legends, regional digital campaigns and a China-focused performance series. The programme will also continue through The Famous CFC in selected markets and offer TMGM clients further hospitality and behind-the-scenes access across Chelsea’s matchday, stadium and training environments.

“Over three years, our relationship with Chelsea FC has evolved from regional activations to high-profile moments, including visibility on the club’s FA Cup shirts and its Asia-Pacific tour,” said TMGM. “Entering our fourth year and extending into the Middle East creates opportunities to connect with more audiences through experiences that reflect the ambition of both organisations.”

Chelsea Football Club said: “TMGM has focused on bringing its clients and our supporters closer to the club through digital-first content and in-person events across Asia-Pacific to great effect. We are pleased to extend the partnership into a fourth year and look forward to building on its momentum across the region and also the Middle East.”

About TMGM

Founded in 2013 in Sydney, Australia, TMGM Group is the Official Regional Partner of Chelsea Football Club. As a broker providing global financial product trading, TMGM is regulated by ASIC (Australia), VFSC (Vanuatu), FSC Mauritius, and FSA (Seychelles).

Disclaimer: Investing in leveraged products carries high risks and is not suitable for all investors. You have no interest in the underlying asset. Read the Client Agreement and other disclosure documents set forth on our website. The above information is provided by TMGM Group (Trademax Australia Limited, ABN 76 162 331 311, AFSL 436416, Trademax Global Markets (SE) Limited, FSA licence number SD224, Trademax Global Limited, VFSC 40356 & Trademax Global Markets (International) Pty Ltd, Company No. 195323, Mauritius Investment Dealer Licence No. GB22201012). 

Helping Advance Industry Collaboration, Innovation and the Future of Global Supply Chains

SEOUL, South Korea and TEANECK, N.J., Sept. 22, 2026 /PRNewswire/ — LX Pantos Americas is proud to announce its Regional Sponsorship and participation in the VMA26 International Trade Symposium, a premier industry event that brings together business leaders, innovators and supply chain professionals to explore the trends, challenges and opportunities shaping the future of global trade and maritime commerce. The event will take place October 13-15 at the Hilton Norfolk The Main in Norfolk, Virginia.

LX Pantos Americas’ participation in VMA26 reflects the company’s deep commitment to maritime transportation and growing investment in Virginia as a strategic gateway for global trade. The company has strengthened its presence in the Commonwealth through recent Memorandums of Understanding with The Port of Virginia and the Virginia Economic Development Partnership (VEDP), reinforcing a shared focus on trade growth, supply chain innovation and economic development. These relationships position LX Pantos Americas to support customers with enhanced connectivity and logistics solutions while contributing to Virginia’s role as a leading hub for international commerce.

As economic ties between the United States and Korea continue to expand, LX Pantos Americas is closely aligned with the opportunities emerging from increased Korean investment across North American manufacturing, infrastructure and transportation networks. The company is actively evaluating opportunities related to the anticipated $150 billion shipbuilding collaboration initiative between the U.S. and Korea and the broader supply chain ecosystem it is expected to support. LX Pantos Americas will host a private executive roundtable during VMA26, bringing together business and supply chain leaders to explore how strategic investment, collaboration and resilient infrastructure can be leveraged to create long-term competitive advantage in a rapidly evolving global marketplace.

LX Pantos Americas CEO David Bang will participate in Late Night Freight on Thursday, October 15, at 11:15 a.m. with host Eric Jehu, VP, Logistics for the VEDP, where he provides primary staff leadership for developing and implementing strategies to promote employment growth within Virginia’s logistics industry. The session will bring together leaders from the legal, pharmaceutical and logistics sectors to discuss the policy, infrastructure and investment priorities shaping the future of supply chains. Bang will share LX Pantos Americas’ “supply chain forward” perspective, emphasizing the importance of collaboration, strategic investment and policy alignment in building resilient supply chains and supporting sustainable industry growth.

Reflecting its commitment to fostering future industry talent, LX Pantos Americas will sponsor a student’s participation in VMA26 and welcome a student guest to its sponsored table at the Maritime Banquet, helping connect emerging professionals with industry leaders while supporting the next generation of maritime, logistics and international trade talent.

“Virginia continues to play an increasingly important role in global trade, making VMA26 an ideal forum to discuss the opportunities created by growing investment and collaboration across the supply chain ecosystem,” said David Bang, CEO of LX Pantos Americas. “As economic ties between the United States and Korea deepen, we see significant potential to strengthen maritime transportation, infrastructure and logistics networks. Through our partnerships in Virginia and engagement with industry leaders at VMA26, we look forward to contributing to conversations that help transform investment into long-term economic growth and supply chain resilience.”

• About LX Pantos Americas

LX Pantos Americas is the Americas regional organization of LX Pantos, a leadingglobal logistics company. With operations spanning across North and South America, LX Pantos Americas combines global scale and standards with deep regional expertise and local execution excellence. The company delivers optimized, end-to-end logistics solutions tailored to support business growth across a wide range of industries, while actively contributing to the communities it serves. LX Pantos Americas brings customers closer to their end markets faster, through all modes of transportation and contract logistics capabilities, including last mile delivery and installation services offered through InstallX, leveraging deep expertise and advanced technical knowledge. The company’s StarLinks service provides reliable and competitive ground transportation solutions across North America powered by its partners and BoxLinks – an innovative joint venture with a major ocean shipping line – enhancing intermodal transport solutions. Driven by a strong dedication to service excellence and client success, LX Pantos Americas helps customers move forward with confidence. Learn more about LX Pantos Americas online and follow it on LinkedIn.

• About LX Pantos

Established in 1977, LX Pantos is a leading global logistics provider headquartered in Korea. It delivers comprehensive logistics solutions across sea, air, rail, and contract logistics through a worldwide network spanning more than 40 countries.

Learn more about LX Pantos online and follow it on LinkedIn.